The latest episode of I See What You Did There explores one of the most talked-about — and often misunderstood — topics in modern medicine: precision medicine. Cheng Zhang, CEO and co-founder of Character Bio, and Mayssa Attar, Ph.D., head of Consumer and Pharmaceutical R&D at Bausch + Lomb, break down what precision medicine actually means, why it matters for patients and how applying genetics and data science to eye health could change how diseases are treated. It's a 20-minute chat on cutting-edge science that feels surprisingly human.

Have an eye health-related idea for an upcoming episode? Drop us a line at [email protected].

Follow Bausch + Lomb on Facebook, Instagram, LinkedIn, X and YouTube.

The inaugural episode of I See What You Did There was recorded at the New York Stock Exchange and features Bausch + Lomb Vision Care President Yang Yang and Vision Care R&D Vice President Bryan Reed. Fresh from an appearance at Bausch + Lomb Investor Day, they explain why there hasn't been a contact lens material breakthrough in over 25 years and share details on an exciting pipeline product that could end that streak and create an entirely new category of lenses. Come for the science, stay for the Blockbuster Video shoutout.

Curious about what else was shared at Investor Day? Watch a replay of the webcast.

Have an eye health-related idea for an upcoming episode? Drop us a line at [email protected].

Follow Bausch + Lomb on Facebook, Instagram, LinkedIn, X and YouTube.